Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» migraines
migraines
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment
BioSpace
Mon, 04/15/24 - 11:06 am
AbbVie
clinical trials
migraines
Qulipta
Lady Gaga’s latest Nurtec ad is out and fans have something to say about it
Medical Marketing and Media
Sun, 04/14/24 - 01:25 pm
Pfizer
migraines
Nurtec
celebrity endorsements
Teva’s Ajovy hits endpoint in Chinese Phase III trial for migraine prevention
Clinical Trials Arena
Thu, 04/11/24 - 11:43 am
Teva Pharmaceutical
clinical trials
Ajovy
migraines
China
FDA declines to approve Shin Nippon Biomedical's migraine drug
Reuters
Thu, 01/18/24 - 11:05 am
FDA
Shin Nippon Biomedical
migraines
Organon pays $50M to pick up rights to pair of Eli Lilly migraine meds in Europe
Fierce Pharma
Mon, 12/18/23 - 10:16 pm
Organon
Eli Lilly
migraines
Europe
Teva’s Ajovy yields positive data in post-hoc migraine analysis
Clinical Trials Arena
Wed, 12/6/23 - 10:20 am
Teva Pharmaceutical
Ajovy
obesity
migraines
post-hoc analysis
Teva drops patent case against Lilly after two Ajovy patents deemed invalid
Fierce Pharma
Tue, 11/28/23 - 11:40 pm
Teva Pharmaceutical
legal
Eli Lilly
Ajovy
patents
migraines
AbbVie’s Migraine Drug Ubrelvy Scores Victory in Phase III Study
BioSpace
Fri, 11/17/23 - 10:00 am
AbbVie
Ubrelvy
ubrogepant
migraines
clinical trials
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters
Tue, 09/26/23 - 09:49 pm
Eli Lilly
Teva Pharmaceutical
migraines
Ajovy
Emgality
patents
legal
Salvia’s neuromodulation therapy for severe migraines shows promise
Clinical Trials Arena
Thu, 08/24/23 - 11:48 am
Salvia
Medtech
neuromodulation
migraines
Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec
BioSpace
Mon, 06/19/23 - 10:31 am
Eli Lilly
Emgality
Pfizer
Nurtec
migraines
NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
Fierce Pharma
Thu, 06/1/23 - 06:41 pm
Biohaven
Pfizer
migraines
NICE
Nurtec
Vydura
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Satsuma peels off staff, cutting head count by 36% to save cash while searching for a deal
Fierce Biotech
Wed, 03/29/23 - 09:37 am
Satsuma Pharmaceuticals
layoffs
migraines
STS101
Pfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packaging
USA Today
Fri, 03/17/23 - 10:18 am
Pfizer
Nurtec ODT
migraines
packaging
product recalls
Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK
Endpoints
Thu, 03/16/23 - 09:46 am
Pfizer
migraines
Royalty Pharma
Biohaven
zavegepant
Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval
BioSpace
Fri, 03/10/23 - 11:32 am
Pfizer
Biohaven
FDA
migraines
nasal spray
zavegepant
Zavzpret
Pfizer cites positive results on nasal spray migraine treatment
Medical Xpress
Thu, 02/16/23 - 08:09 pm
Pfizer
migraines
The Lancet
nasal spray
zavegepant
Satsuma in the red after 2nd phase 3 migraine flop spurs search for strategic alternatives
Fierce Biotech
Mon, 11/14/22 - 10:48 am
Satsuma Pharmaceuticals
clinical trials
migraines
STS101
intra-nasal drug delivery
Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight
Fierce Pharma
Thu, 11/10/22 - 10:12 pm
Eli Lilly
legal
migraines
Ajovy
patents
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »